NEW YORK, Aug. 12, 2014 /PRNewswire/ Reportlinker.com announces that a new market research report is available in its catalogue: Global Hematology Instruments and Reagents Industry http://www.reportlinker.com/p02284903/Global-Hematology-Instruments-and-Reagents-Industry.html

Excerpt from: Global Hematology Instruments and Reagents Industry

Hyderabad,Aug 12:

Global skin healthcare company PhotoMedex has entered the Indian market with its new laser technology for treatment of psoriasis and vitiligo (a skin condition causing white patches).

The firm opened its VTRAC brand of clinics in Hyderabad today, offering its certified laser technology to treat the skin diseases.

Dolev Rafaeli, CEO, said the company was launching five clinics in Hyderabad through the franchise route. We today operate about 2,500 VTRAC clinics all over the world, the majority being in the US and Europe. We believe our clinics hold the potential to transform vitiligo and psoriasis patients, he told mediapersons here.

The technology is a FDA-cleared and clinically proven excimer treatment used in multi-centre clinical studies. The VTRAC delivers a highly targeted therapeutic level of UVB light to areas of the skin affected by the disease, without harming the surrounding tissue. The UVB light stimulates re-pigmentation of the areas that have lost colour.

Market studies have shown that an estimated 4.4-6.5 per cent of the Indian population have vitiligo or psoriasis, which have no cure.

(This article was published on August 12, 2014)

See the article here: PhotoMedex enters India with vitiligo treatment

Read more here:
August 2014 IPS Cell Therapy IPS Cell Therapy

Comments are closed.